Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder

dc.contributor.author Meyer, Jacob
dc.contributor.author Crombie, Kevin
dc.contributor.author Meyer, Jacob
dc.contributor.author Cook, Dane
dc.contributor.author Hillard, Cecilia
dc.contributor.author Koltyn, Kelli
dc.contributor.department Kinesiology
dc.date 2019-11-13T18:06:04.000
dc.date.accessioned 2020-06-30T05:45:44Z
dc.date.available 2020-06-30T05:45:44Z
dc.date.copyright Tue Jan 01 00:00:00 UTC 2019
dc.date.issued 2019-04-01
dc.description.abstract <p>MEYER, J. D., K. M. CROMBIE, D. B. COOK, C. J. HILLARD, and K. F. KOLTYN. Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder. Med. Sci. Sports Exerc., Vol. 51, No. 9, pp. 1909–1917, 2019. The endocannabinoid (eCB) system is implicated in the pathophysiology of depression and is responsive to acute exercise in healthy adults. Purpose: We aimed to describe acute changes in serum eCB across a prescribed moderate (MOD) and a self-selected/preferred (PREF) intensity exercise session in women with major depressive disorder (MDD) and determine relationships between changes in eCB and mood states. Methods: Women with MDD (n = 17) exercised in separate sessions for 20 min on a cycle ergometer at both MOD or PREF in a within-subjects design. Blood was drawn before and within 10 min after exercise. Serum concentrations of eCB (anandamide [AEA], 2-arachidonoylglycerol) and related lipids (palmitoylethanolamine, oleoylethanolamine, 2-oleoylglycerol) were quantified using stable isotope-dilution, liquid chromatography/mass spectrometry/mass spectrometry. The profile of mood states and state-trait anxiety inventory (state only) were completed before, 10 min and 30 min postexercise. Results: Significant elevations in AEA (P = 0.013) and oleoylethanolamine (P = 0.024) occurred for MOD (moderate effect sizes: Cohen’s d = 0.58 and 0.41, respectively). Significant (P < 0.05) moderate negative associations existed between changes in AEA and mood states for MOD at 10 min (depression, confusion, fatigue, total mood disturbance [TMD] and state anxiety) and 30 min postexercise (confusion, TMD and state anxiety). Significant (P < 0.05) moderate negative associations existed between 2-arachidonoylglycerol and mood states at 10 min (depression and confusion) and 30 min postexercise (confusion and TMD). Changes in eCB or related lipids or eCB–mood relationships were not found for PREF. Conclusion: Given the broad, moderate–strength relationships between improvements in mood states and eCB increases after MOD, it is plausible that the eCB system contributes to the mood-enhancing effects of prescribed acute exercise in MDD. Alternative mechanisms are likely involved in the positive mood state effects of preferred exercise</p>
dc.description.comments <p>This article is published as 3. Meyer J, Crombie K, Cook D, Hillard C, Koltyn K (2019). Serum endocannabinoid and mood changes after exercise in major depressive disorder. Medicine and Science in Sports and Exercise. 51(9): 1909–1917. doi: <a target="_blank">10.1249/MSS.0000000000002006</a>. </p>
dc.format.mimetype application/pdf
dc.identifier archive/lib.dr.iastate.edu/kin_pubs/56/
dc.identifier.articleid 1055
dc.identifier.contextkey 15765976
dc.identifier.s3bucket isulib-bepress-aws-west
dc.identifier.submissionpath kin_pubs/56
dc.identifier.uri https://dr.lib.iastate.edu/handle/20.500.12876/52539
dc.language.iso en
dc.source.bitstream archive/lib.dr.iastate.edu/kin_pubs/56/2019_MeyerJ_cc_Serum_Endocannabinoid.pdf|||Sat Jan 15 00:57:11 UTC 2022
dc.source.uri 10.1249/MSS.0000000000002006
dc.subject.disciplines Exercise Science
dc.subject.disciplines Kinesiology
dc.subject.disciplines Kinesiotherapy
dc.subject.disciplines Movement and Mind-Body Therapies
dc.subject.keywords 2-Arachidonoylglycerol
dc.subject.keywords N-arachidonoylethanolamine
dc.subject.keywords Acute
dc.subject.keywords Aerobic
dc.subject.keywords Preferred intensity
dc.subject.keywords Moderate Intensity
dc.title Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder
dc.type article
dc.type.genre article
dspace.entity.type Publication
relation.isAuthorOfPublication 6d25a191-dd56-4965-a726-6dfe139e771a
relation.isOrgUnitOfPublication f7b0f2ca-8e43-4084-8a10-75f62e5199dd
File
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
2019_MeyerJ_cc_Serum_Endocannabinoid.pdf
Size:
270.75 KB
Format:
Adobe Portable Document Format
Description:
Collections